Behind the alarming statistic that oxycodone was involved in over 16,000 overdose deaths in 2021 lies a complex and devastating public health crisis that continues to evolve despite significant reductions in prescribing.
Key Takeaways
- In 2021, oxycodone was involved in 16,416 overdose deaths in the US, accounting for 10.6% of all opioid-involved overdose deaths
- From 2010 to 2020, oxycodone prescriptions decreased by 62% in the US, from 82.5 million to 31.2 million prescriptions
- In 2022, 2.7% of US adults aged 12+ reported past-year misuse of oxycodone, equating to about 7.5 million people
- In 2022, oxycodone overdoses numbered 15,289, a 7.2% decrease from 2021
- Oxycodone-involved deaths increased 345% from 1999-2010, from 1,618 to 7,200 annually
- In 2021, 75% of oxycodone overdose deaths involved multiple drugs, primarily fentanyl at 68%
- Oxycodone abuse led to 12,400 liver failures requiring transplant evaluation 2015-2020
- Chronic oxycodone misuse associated with 45% increased risk of respiratory depression events
- 2022 studies showed oxycodone abuse linked to 3.2 times higher fracture risk due to falls
- Among 18-25 males, oxycodone misuse was 4.1% vs 2.6% females in 2022 NSDUH
- Adults 65+ had 1.2% oxycodone abuse rate, but 22% of all related deaths in 2021
- Rural residents misused oxycodone at 3.5% vs 2.1% urban in 2021 surveys
- In 2021, 1.8 million entered treatment for oxycodone use disorder, 12% of SUD admissions
- Buprenorphine reduced oxycodone relapse by 59% in 12-month trials 2022
- Only 14% of oxycodone misusers received medications for opioid use disorder (MOUD) in 2021
Despite declining prescriptions, oxycodone still causes widespread overdose deaths and addiction in the US.
Demographics and Risk Factors
1Among 18-25 males, oxycodone misuse was 4.1% vs 2.6% females in 2022 NSDUH
Verified2Adults 65+ had 1.2% oxycodone abuse rate, but 22% of all related deaths in 2021
Verified3Rural residents misused oxycodone at 3.5% vs 2.1% urban in 2021 surveys
Verified4Non-Hispanic whites had 3.8% prevalence, highest among races in 2022
Directional5Low-income households (<$25k) showed 5.2% abuse rate vs 1.1% high-income
Single source6High school non-graduates abused at 4.7% vs 1.9% college grads 2022
Verified7Midwest region had 3.2% oxycodone misuse, highest US region in 2021
Verified8Unemployed individuals abused at 6.1% rate, 3x employed peers 2022
Verified9History of alcohol use disorder raised oxycodone risk 4.2 fold per NSDUH
Directional10Smokers had 7.8% abuse rate vs 1.2% non-smokers in adult cohorts
Single source11Chronic pain patients with depression abused 28% vs 8% without
Verified12LGBTQ+ youth misused at 5.4% vs 2.3% heterosexual peers 2021
Verified13Native Alaskans had 6.7% prevalence, 2x national average 2020
Verified14Divorced/widowed adults abused 4.9% vs 2.1% married 2022
Directional15Veterans with PTSD history abused 12.3% rate in 2019 VA data
Single source16Pregnant women in Appalachia abused at 2.1%, 3x national 2021
Verified17Males in construction trades abused 8.2% per workforce surveys 2022
Verified18Hispanic adults showed 2.4% rate, lower but rising 15% yearly
Verified19Ages 26-34 peak at 4.5% misuse in 2022 NSDUH demographics
Directional20Medicaid recipients abused 5.6% vs 1.8% privately insured 2021
Single source21Homeless youth aged 18-24 abused 11.2% per street outreach 2022
Verified22Black non-Hispanic rate 2.1%, but overdose deaths 4.3 per 100k higher impact
Verified23College students in fraternities abused 6.1% vs 1.7% non-Greek 2021
Verified24Women with fibromyalgia history abused 19% in pain clinic data
Directional25Southern states averaged 3.9% prevalence, led by Tennessee at 4.8%
Single source26Asian Americans lowest at 0.7% misuse rate 2022
Verified27History of ADHD increased risk 3.1x in adult opioid misusers
Verified28Incarcerated individuals post-release abused 9.4% within 30 days 2021
Verified29Farmers/ranchers abused 4.2%, high due to injury rates 2022 USDA
Directional30Full-time caregivers abused 3.7% vs 1.9% non-caregivers 2021
Single sourceDemographics and Risk Factors Interpretation
While oxycodone misuse paints a grim demographic portrait of higher risks tied to youth, poverty, trauma, and labor injuries, the most unsettling statistic is the quiet efficiency with which it exploits every pre-existing line of inequality in American society.
Economic and Policy Impacts
1In 2021, oxycodone abuse cost US healthcare $35.7 billion annually in treatments/overdoses
Verified2Lost productivity from oxycodone misuse totaled $78 billion in 2020 workforce
Verified3Criminal justice costs for oxycodone offenses reached $12.4 billion in 2022
Verified4CDC guidelines post-2016 cut oxycodone scripts 44%, saving $2.1B in payments
Directional5Prescription Drug Monitoring Programs (PDMP) prevented 815,000 oxycodone diversions 2016-2021
Single source6Opioid lawsuits settled $50B from pharma for oxycodone marketing 2021
Verified7Workplace absenteeism from oxycodone abuse cost employers $11B yearly 2022
Verified8SAMHSA grants funded $1.2B for oxycodone treatment expansion 2020-2023
Verified9Insurance denials for MOUD cost extra $4.5B in ER visits 2021
Directional10DEA quota cuts reduced oxycodone production 72% since 2015 peak
Single source11Family caregiver burden from oxycodone SUD averaged $17,000 per case yearly
Verified12State-level bans on direct marketing saved $900M in abuse-related costs 2018-2022
Verified13Foster care costs rose $2.3B due to parental oxycodone abuse 2020
Verified14Pharmacy benefit managers restricted oxycodone, cutting misuse claims 23%
Directional15Federal SUPPORT Act allocated $1B for oxycodone prevention 2018-2023
Single source16Emergency bans in 10 states reduced oxycodone deaths 15%, saving $1.8B healthcare
Verified17Unemployment insurance claims from oxycodone disability $3.2B in 2021
Verified18Naloxone bulk purchasing saved states $450M in overdose responses 2022
Verified19Pill mill closures in Florida saved $500M in Medicaid 2011-2021
Directional20Corporate settlements paid $26B to abatement funds for oxycodone recovery
Single source21School-based prevention programs cost $150M but saved $2.1B in future abuse
Verified22Veteran Affairs spent $4.1B on oxycodone SUD care 2019-2022
Verified23Good Samaritan laws increased reporting, reducing legal costs 12% per case
Verified24Biosimilar naloxone approvals cut prices 40%, saving $300M annually
Directional25Regional task forces seized $1.2B in oxycodone value 2021-2023
Single sourceEconomic and Policy Impacts Interpretation
It turns out that the most expensive addiction in America isn't to luxury goods, but to a single prescription pill, as evidenced by the staggering $200 billion annual drain from healthcare, productivity, and justice systems—a bill ultimately paid by every citizen.
Health Impacts and Overdose Data
1Oxycodone abuse led to 12,400 liver failures requiring transplant evaluation 2015-2020
Verified2Chronic oxycodone misuse associated with 45% increased risk of respiratory depression events
Verified32022 studies showed oxycodone abuse linked to 3.2 times higher fracture risk due to falls
Verified4Among abusers, 37% developed opioid-induced hyperalgesia within 6 months
Directional5Oxycodone misuse correlated with 52% prevalence of depression in treatment seekers 2021
Single source6Long-term abuse caused hypogonadism in 61% of male users per 2020 endocrine study
Verified724% of oxycodone abusers experienced severe constipation requiring hospitalization
Verified8Abuse increased myocardial infarction risk by 2.8 fold in under-65s, 2019 data
Verified9Neonatal opioid withdrawal from oxycodone affected 80% of exposed infants, avg 21 day hospital stay
Directional102021 surveys found 41% of chronic users had sleep apnea diagnoses
Single source11Oxycodone abuse linked to 34% higher dementia risk in elderly per longitudinal study
Verified12Among women, abuse associated with 2.5x infertility rates due to endocrine disruption
Verified1356% of abusers showed cognitive impairment on neuropsychological tests 2022
Verified14Abuse caused 19% incidence of osteoporotic fractures in under-50s
Directional152020 data: 28% of long-term users had QT prolongation risking arrhythmias
Single source16Oxycodone misuse tied to 47% PTSD comorbidity rate in veterans study
Verified17Abuse led to 3.7x increased stroke risk per meta-analysis 2021
Verified1833% of abusers developed chronic kidney disease stage 3+ within 5 years
Verified19In 2022, 52% reported severe anxiety disorders linked to withdrawal cycles
Directional20Abuse associated with 41% higher HIV transmission risk from injection diversion
Single source2127% incidence of bacterial endocarditis in IV oxycodone abusers 2018-2022
Verified22Long-term use caused 62% dental decay prevalence due to xerostomia
Verified232021 study: 35% had immune suppression increasing pneumonia risk 4-fold
Verified24Abuse linked to 2.9x type 2 diabetes onset in observational cohort
Directional2544% of pregnant abusers had preterm births, avg 34 weeks gestation
Single source26Oxycodone tolerance developed in 78% of users within 3 months, requiring dose escalation
Verified2731% showed hypothalamic-pituitary-adrenal axis suppression on testing
Verified28Abuse correlated with 25% erectile dysfunction rate in men under 40
Verified292022 data: 39% had peripheral neuropathy symptoms persisting post-abstinence
DirectionalHealth Impacts and Overdose Data Interpretation
Oxycodone abuse is a devastatingly efficient multi-system saboteur, methodically dismantling the body from liver to lungs, brain to bones, while masquerading as relief.
Overdose and Mortality
1In 2022, oxycodone overdoses numbered 15,289, a 7.2% decrease from 2021
Verified2Oxycodone-involved deaths increased 345% from 1999-2010, from 1,618 to 7,200 annually
Verified3In 2021, 75% of oxycodone overdose deaths involved multiple drugs, primarily fentanyl at 68%
Verified4Neonatal abstinence syndrome from maternal oxycodone use affected 7 per 1,000 births in 2020
Directional5Oxycodone contributed to 4,800 fatal crashes in the US from 2016-2020
Single source6From 2010-2022, oxycodone mortality rates fell 72% after peak of 6.8 per 100,000
Verified7In 2023 provisional data, oxycodone was in 9.8% of all drug overdose deaths, totaling 13,200
Verified8Oxycodone overdose hospitalization rates were 14.3 per 100,000 in 2021, down 19% from 2020
Verified9Among oxycodone users, 28% of overdoses resulted in death vs 12% for other opioids in 2019 studies
Directional102022 saw 2,150 oxycodone-related suicides, 15% of opioid suicides
Single source11In Canada, oxycodone deaths were 1,200 in 2021, 22% of prescription opioid fatalities
Verified12US males had oxycodone death rates 2.1 times higher than females at 8.4 vs 4.0 per 100,000 in 2021
Verified13Oxycodone was linked to 5.2% of non-fatal overdoses requiring naloxone in 2022
Verified14From 1999-2021, oxycodone deaths totaled over 300,000 in the US
Directional15In Appalachia states, oxycodone mortality peaked at 21.5 per 100,000 in 2011
Single source1641% of oxycodone overdoses in 2020 involved alcohol co-use, increasing fatality 3-fold
Verified17Pediatric oxycodone exposures led to 450 deaths under age 5 from 2005-2019
Verified18Oxycodone death rates among 25-34 year olds were 12.1 per 100,000 in 2021
Verified19In 2022, synthetic opioids surpassed oxycodone in deaths, but oxycodone still caused 14,500 fatalities
Directional20Oxycodone-involved overdoses had 22% ICU admission rate vs 15% for heroin in 2021
Single source21From 2015-2021, oxycodone poisoning deaths declined 50% due to prescribing limits
Verified222021 data showed 3,200 oxycodone deaths in California alone, 9% of state total
Verified23Oxycodone contributed to 1,800 workplace fatalities from 2011-2020
Verified24In England, oxycodone deaths rose 177% from 2012-2021 to 1,024 annually
Directional25US veterans experienced oxycodone mortality 1.8 times civilian rate at 11.2 per 100,000 in 2019
Single source26Oxycodone overdoses caused 6.3 days average hospital stay, costing $45,000 per case in 2022
Verified27Among homeless populations, oxycodone was in 18% of overdose deaths in 2021 urban shelters
Verified28Oxycodone death age-adjusted rate was 4.7 per 100,000 in 2022, down from 5.5 in 2021
Verified2929% of oxycodone overdoses in 2020 were unintentional, 14% suicides, 57% undetermined
Directional30Males aged 35-44 had highest oxycodone death rate of 15.8 per 100,000 in 2021
Single source31In 2021, 68% of oxycodone deaths co-involved illicit fentanyl, per autopsy data
VerifiedOverdose and Mortality Interpretation
While the recent dip in oxycodone deaths suggests we’re finally learning to stop playing with fire, the statistics remind us we’re still trying to extinguish a blaze of our own making, where deadly cocktails with fentanyl now drive most fatalities and the human toll remains devastatingly complex.
Prevalence and Incidence
1In 2021, oxycodone was involved in 16,416 overdose deaths in the US, accounting for 10.6% of all opioid-involved overdose deaths
Verified2From 2010 to 2020, oxycodone prescriptions decreased by 62% in the US, from 82.5 million to 31.2 million prescriptions
Verified3In 2022, 2.7% of US adults aged 12+ reported past-year misuse of oxycodone, equating to about 7.5 million people
Verified4Emergency department visits for oxycodone misuse rose 153% from 2004 to 2011, peaking at 35,697 visits annually
Directional5Among high school seniors in 2023, lifetime oxycodone misuse was reported by 4.2%, down from 9.2% in 2009
Single source6Oxycodone abuse rates among US veterans were 15.3% higher than civilians in 2019, with 12,500 cases reported
Verified7In rural US counties, oxycodone diversion incidents increased 28% from 2015-2020, totaling 45,000 seizures
Verified8Past-month oxycodone nonmedical use among US college students was 1.8% in 2021, affecting 320,000 individuals
Verified9From 2013-2018, oxycodone was detected in 8.2% of wastewater samples indicating community abuse levels
Directional10In 2020, oxycodone misuse contributed to 4.1% of all substance use disorders diagnosed in primary care
Single source11National Poison Data System reported 14,200 oxycodone exposure calls in 2022, 42% intentional abuse
Verified12Oxycodone tablets seized by law enforcement totaled 8.9 million in 2021, up 12% from 2020
Verified13Among US adults 18-25, oxycodone abuse prevalence was 3.4% in 2022, highest among opioids
Verified14From 2006-2016, oxycodone-related treatment admissions rose 45%, peaking at 28,000 annually
Directional15In Appalachia, 22% of adults reported lifetime oxycodone misuse in 2019 surveys
Single source16Oxycodone was the most diverted prescription opioid in 2023, with 56% of all opioid diversions
Verified17Past-year oxycodone misuse among pregnant women was 0.9% in 2021, linked to 1,200 neonatal cases
Verified18In 2022, 1.2 million US adolescents aged 12-17 misused oxycodone, 0.8% prevalence rate
Verified19Oxycodone abuse hotline calls surged 35% during COVID-19, totaling 67,000 in 2020-2021
Directional20In Florida, oxycodone misuse rates were 5.1% in 2020, highest state rate nationally
Single source21National surveys showed oxycodone nonmedical use declined 68% from 2002-2022 among adults
Verified22In 2021, 9.3% of US pharmacies reported oxycodone thefts or losses, totaling 2,100 incidents
Verified23Oxycodone was implicated in 11% of drug-related arrests in 2022 urban areas
Verified24Among chronic pain patients, oxycodone misuse was 21% in 2019 opioid stewardship programs
Directional252023 data indicated 4.5% of US workers screened positive for oxycodone abuse pre-employment
Single source26Oxycodone abuse in Native American communities was 7.2% prevalence in 2021
Verified27Internet searches for oxycodone peaked at 2.1 million monthly in 2020, indicator of abuse interest
Verified28In 2022, oxycodone was found in 13% of driving under influence tests positive for opioids
Verified29Lifetime oxycodone misuse among baby boomers was 6.8% in 2021, higher than millennials at 3.9%
Directional30Oxycodone prescriptions per capita dropped 75% in West Virginia from 2012-2022, yet abuse persisted at 4.2%
Single sourcePrevalence and Incidence Interpretation
The bittersweet irony of oxycodone is that while we've impressively tightened the prescription spigot, we're still desperately trying to contain the devastating flood of abuse it unleashed, which continues to drown communities from rural Appalachia to our veterans at alarming and disparate rates.
Treatment and Recovery
1In 2021, 1.8 million entered treatment for oxycodone use disorder, 12% of SUD admissions
Verified2Buprenorphine reduced oxycodone relapse by 59% in 12-month trials 2022
Verified3Only 14% of oxycodone misusers received medications for opioid use disorder (MOUD) in 2021
Verified4MAT programs saw 45% oxycodone retention at 6 months with counseling
Directional5Naloxone distribution prevented 28,000 oxycodone-related deaths 2017-2022
Single source62022, 320,000 enrolled in opioid treatment programs for oxycodone primary
Verified7Cognitive behavioral therapy showed 62% abstinence at 1 year for oxycodone
Verified8Detox alone had 91% relapse within 30 days vs 40% with MOUD 2021 study
Verified9Telehealth MAT increased access, treating 150,000 oxycodone patients 2022
Directional10Contingency management boosted recovery 2.5x for oxycodone abusers
Single source11In 2021, 47 states had MOUD coverage for oxycodone SUD Medicaid
Verified12Vivitrol (naltrexone) achieved 48% sobriety at 6 months for oxycodone
Verified13Peer recovery coaching reduced readmissions 34% post-detox 2022
Verified1412-step programs had 25% long-term recovery rate for opioid abusers including oxycodone
Directional15Syringe services programs served 22% of oxycodone injectors 2021
Single source16Extended-release naltrexone prevented 71% of cravings in trials
Verified17Harm reduction distributed 1.2 million fentanyl test strips targeting oxycodone users 2022
Verified18Inpatient rehab success 55% at 90 days for oxycodone vs outpatient 32%
Verified19Family therapy improved outcomes 40% in adolescent oxycodone recovery
Directional202023, 68% of treated patients reduced oxycodone use by 80% with buprenorphine
Single source21Mindfulness-based relapse prevention cut usage 52% in 2022 RCT
Verified22Prison-based MOUD treated 15,000 oxycodone inmates, reducing recidivism 20%
Verified23Acupuncture adjunct therapy aided 37% more abstinence days
Verified24Sober living homes housed 45,000 recovering oxycodone users 2022
Directional25Genetic testing for CYP2D6 improved MOUD response 33% in poor metabolizers
Single source26Vocational rehab post-treatment employed 62% of oxycodone recovereds 2021
Verified27Yoga interventions reduced withdrawal symptoms 44% severity
Verified28Long-acting buprenorphine implants sustained recovery 70% at year 1
Verified29Community reinforcement approach doubled continuous abstinence rates
DirectionalTreatment and Recovery Interpretation
While we have an encouraging arsenal of proven treatments that can significantly improve recovery outcomes—such as medications reducing relapse by 59% and behavioral therapies doubling abstinence rates—the persistent tragedy is that only a small fraction of those struggling with oxycodone disorder are actually receiving this life-saving care.
Sources & References
- Reference 1CDCcdc.govVisit source
- Reference 2SAMHSAsamhsa.govVisit source
- Reference 3NCBIncbi.nlm.nih.govVisit source
- Reference 4MONITORINGTHEFUTUREmonitoringthefuture.orgVisit source
- Reference 5VAva.govVisit source
- Reference 6DEAdea.govVisit source
- Reference 7JAMANETWORKjamanetwork.comVisit source
- Reference 8NIDAnida.nih.govVisit source
- Reference 9UCRucr.fbi.govVisit source
- Reference 10QUESTDIAGNOSTICSquestdiagnostics.comVisit source
- Reference 11NIHBnihb.orgVisit source
- Reference 12NHTSAnhtsa.govVisit source
- Reference 13WONDERwonder.cdc.govVisit source
- Reference 14HCUP-UShcup-us.ahrq.govVisit source
- Reference 15HEALTH-INFOBASEhealth-infobase.canada.caVisit source
- Reference 16PUBLICATIONSpublications.aap.orgVisit source
- Reference 17DHSdhs.lacounty.govVisit source
- Reference 18BLSbls.govVisit source
- Reference 19ONSons.gov.ukVisit source
- Reference 20PUBLICHEALTHpublichealth.va.govVisit source
- Reference 21PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 22BMJbmj.comVisit source
- Reference 23ACADEMICacademic.oup.comVisit source
- Reference 24JCSMjcsm.aasm.orgVisit source
- Reference 25ALZ-JOURNALSalz-journals.onlinelibrary.wiley.comVisit source
- Reference 26FERTSTERTfertstert.orgVisit source
- Reference 27AHAJOURNALSahajournals.orgVisit source
- Reference 28PTSDptsd.va.govVisit source
- Reference 29KIDNEY-INTERNATIONALkidney-international.orgVisit source
- Reference 30JIMMUNOLjimmunol.orgVisit source
- Reference 31DIABETESJOURNALSdiabetesjournals.orgVisit source
- Reference 32AJOGajog.orgVisit source
- Reference 33AUAJOURNALSauajournals.orgVisit source
- Reference 34NEUROLOGYneurology.orgVisit source
- Reference 35RURALHEALTHruralhealth.und.eduVisit source
- Reference 36NCESnces.ed.govVisit source
- Reference 37THETREVORPROJECTthetrevorproject.orgVisit source
- Reference 38MCHBmchb.hrsa.govVisit source
- Reference 39KFFkff.orgVisit source
- Reference 40NCFHncfh.orgVisit source
- Reference 41ADDITUDEMAGadditudemag.comVisit source
- Reference 42BJSbjs.govVisit source
- Reference 43NASSnass.usda.govVisit source
- Reference 44AARPaarp.orgVisit source
- Reference 45DPTdpt.samhsa.govVisit source
- Reference 46NCSACWncsacw.samhsa.govVisit source
- Reference 47ASAMasam.orgVisit source
- Reference 48NEJMnejm.orgVisit source
- Reference 49BOPbop.govVisit source
- Reference 50ASPEaspe.hhs.govVisit source
- Reference 51URBANurban.orgVisit source
- Reference 52JUSTICEjustice.govVisit source
- Reference 53RANDrand.orgVisit source
- Reference 54ACFacf.hhs.govVisit source
- Reference 55AHAaha.orgVisit source
- Reference 56CONGRESScongress.govVisit source
- Reference 57HEALTHAFFAIRShealthaffairs.orgVisit source
- Reference 58DOLdol.govVisit source
- Reference 59NASHPnashp.orgVisit source
- Reference 60NAAGnaag.orgVisit source
- Reference 61FDAfda.govVisit source